We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Innovative Implant Treats Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 18 Sep 2018
A non-fusion, motion-preserving implant used following decompression procedures helps stabilize the lumbar spine without resorting to fusion.

The Paradigm Spine (New York, NY, USA) coflex device is a small, U-shaped interlaminar titanium stabilization device indicated for use after a spinal decompression procedure on one or two level contiguous lumbar motion segments (L1-L5) in skeletally mature patients, with at least moderate impairment in function, who experience relief during flexion from leg, buttocks, or/and groin pain (with or without back pain), and who previously underwent at least six months of non-operative treatment. More...
The device is implanted midline between adjacent lamina, and is available in five different anatomical sizes.

During the clinical procedure, the “U” is positioned horizontally, with the apex oriented anteriorly and the two long side arms paralleling the long axis of the spinous processes. The bone-facing surfaces are ridged to provide resistance to migration. Features include a biocompatible and x-ray visible titanium composition; crimped wings for increased primary stability; a center of rotation close to the spinal canal to provide increased rotational stability; stress reduction on facet joints; a large contact area for optimized stress distribution; protection of posterior elements; and maintenance of foraminal height.

“There is now potentially a more effective surgical option between the two typical treatments for lumbar spinal stenosis, and we are proud to lead the way in changing the standard of care for surgeons and their patients with this diagnosis,” said Marc Viscogliosi, chairman and CEO of Paradigm Spine. “Paradigm Spine has worked diligently to build the pieces of the puzzle in establishing coflex as the new standard of care for the treatment of moderate to severe lumbar spinal stenosis.”

Lumbar spinal stenosis is a debilitating and degenerative disease in older patients, often associated with significant leg and back pain, leg numbness, and weakness, which causes a significant reduction activity. Decompression alone is effective at relieving pain symptoms caused by lumbar spinal stenosis, but long term symptomatic relief is elusive, often resulting in subsequent opioid pain control, epidural injections for pain management, or additional surgeries for conversion to a fusion. Decompression with fusion has proven to provide pain relief and stabilize the diseased segment, but may lead to adjacent level disease requiring subsequent surgeries.

Related Links:
Paradigm Spine


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.